TransAct VP reports RSUs and stock options
TransAct Technologies executive Robert William Campbell III, VP and Corporate Controller, filed a Form 3 reporting his equity holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
TransAct Technologies executive Robert William Campbell III, VP and Corporate Controller, filed a Form 3 reporting his equity holdings. He lists Restricted Stock Units covering 2,865 and 2,800 shares of common stock, plus stock options for 5,000, 1,000 and 3,000 shares at exercise prices of $4.28, $7.07 and $6.80 expiring between 2032 and 2034. Footnotes state portions of these options are already vested and exercisable.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Campbell Robert William III
Role
VP, Corporate Controller
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 9,000 contracts (Direct);
Restricted Stock Units — 5,665 contracts (Direct)
Footnotes (5)
- F1. Represents shares of Common Stock issuable upon exercise of a non-qualified stock option granted to the Reporting Person on November 2, 2022 under the Company's 2014 Equity Incentive Plan, as Amended and Restated. The option becomes exercisable 25% per year on each anniversary date of the grant. As of the date of filing, the option is vested and exercisable with respect to 3,750 shares.
- F2. Represents shares of Common Stock issuable upon exercise of a non-qualified stock option granted to the Reporting Person on March 1, 2023 under the Company's 2014 Equity Incentive Plan, as Amended and Restated. The option becomes exercisable 25% per year on each anniversary date of the grant. As of the date of filing, the option is vested and exercisable with respect to 750 shares.
- F3. Represents shares of Common Stock issuable upon exercise of a non-qualified stock option granted to the Reporting Person on February 29, 2024 under the Company's 2014 Equity Incentive Plan, as Amended and Restated. The option becomes exercisable 25% per year on each anniversary date of the grant. As of the date of filing, the option is vested and exercisable with respect to 1,500 shares.
- F4. Restricted Stock Units issued on April 7, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, cliff vesting on the second anniversary date of the grant and converting to common stock on a one-for-one basis.
- F5. Restricted Stock Units issued on February 25, 2026 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, cliff vesting on the second anniversary date of the grant and converting to common stock on a one-for-one basis.
Key Figures
RSUs grant 1: 2,865 shares
RSUs grant 2: 2,800 shares
Option grant 2022: 5,000 shares at $4.28
+5 more
8 metrics
RSUs grant 1
2,865 shares
Restricted Stock Units underlying common stock
RSUs grant 2
2,800 shares
Restricted Stock Units underlying common stock
Option grant 2022
5,000 shares at $4.28
Non-qualified stock option, expires 2032-11-02
Option grant 2023
1,000 shares at $7.07
Non-qualified stock option, expires 2033-03-01
Option grant 2024
3,000 shares at $6.80
Non-qualified stock option, expires 2034-02-28
Vested from 2022 option
3,750 shares
Vested and exercisable as of filing
Vested from 2023 option
750 shares
Vested and exercisable as of filing
Vested from 2024 option
1,500 shares
Vested and exercisable as of filing
Key Terms
Restricted Stock Units, non-qualified stock option, cliff vesting, 2014 Equity Incentive Plan, +1 more
5 terms
Restricted Stock Units financial
"Restricted Stock Units issued on April 7, 2025 pursuant to the Company's 2014 Equity Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
non-qualified stock option financial
"shares of Common Stock issuable upon exercise of a non-qualified stock option granted to the Reporting Person"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
cliff vesting financial
"Restricted Stock Units issued on April 7, 2025 ... cliff vesting on the second anniversary date of the grant"
2014 Equity Incentive Plan financial
"under the Company's 2014 Equity Incentive Plan, as Amended and Restated"
one-for-one basis financial
"Restricted Stock Units ... converting to common stock on a one-for-one basis"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the TransAct Technologies (TACT) Form 3 for Robert Campbell report?
The Form 3 reports Robert William Campbell III’s existing equity holdings, including Restricted Stock Units and stock options on TransAct common stock. It does not show new buys or sells, only his current compensation-linked positions and their key terms such as strike prices and expirations.
How many Restricted Stock Units does Robert Campbell hold in TransAct (TACT)?
Robert Campbell reports two Restricted Stock Unit positions tied to TransAct common stock: 2,865 underlying shares and 2,800 underlying shares. Both RSU grants convert into common stock on a one-for-one basis after they meet their cliff vesting requirements under the company’s equity plan.
What stock options are disclosed for Robert Campbell in the TACT Form 3?
The filing lists three non-qualified stock options for 5,000, 1,000 and 3,000 TransAct common shares. Their exercise prices are $4.28, $7.07 and $6.80 per share, with expiration dates in 2032, 2033 and 2034, respectively, reflecting long-dated compensation awards.
What are the vesting terms of Robert Campbell’s TransAct stock options?
Each non-qualified stock option vests 25% per year on the grant’s anniversary date. Footnotes state that as of the filing date, options are vested and exercisable for 3,750 shares from the 2022 grant, 750 shares from the 2023 grant, and 1,500 shares from the 2024 grant.
How do Robert Campbell’s TransAct RSUs vest and convert to common stock?
The RSUs granted on April 7, 2025 and February 25, 2026 use cliff vesting on the second anniversary of each grant. Once vested, each Restricted Stock Unit converts into one share of TransAct common stock, aligning Campbell’s compensation with long-term shareholder value.
Does the TransAct (TACT) Form 3 show any stock purchases or sales by Robert Campbell?
No, the Form 3 only records existing holdings, not new trades. The transaction codes are unknown and the filing’s summary shows no buy or sell activity, just RSUs and stock options already granted as part of Campbell’s compensation package at TransAct Technologies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates